SILDENAFIL POWDER,

SILDENAFIL POWDER, was reported 35874 times

These side effects are most commonly reported by patients taking SILDENAFIL POWDER,:

# Side effect Count
0 DYSPNOEA 4515
1 HEADACHE 2910
2 DEATH 2711
3 DIARRHOEA 2360
4 NAUSEA 2214
5 FATIGUE 2164
6 DIZZINESS 1808
7 DRUG INEFFECTIVE 1783
8 PNEUMONIA 1681
9 PULMONARY ARTERIAL HYPERTENSION 1445
10 OFF LABEL USE 1427
11 VOMITING 1420
12 CONDITION AGGRAVATED 1389
13 HYPOTENSION 1371
14 COUGH 1263
15 MALAISE 1241
16 PAIN 1151
17 FLUID RETENTION 1101
18 CHEST PAIN 1059
19 PULMONARY HYPERTENSION 1054
20 PAIN IN EXTREMITY 998
21 ASTHENIA 949
22 OXYGEN SATURATION DECREASED 934
23 PYREXIA 917
24 OEDEMA PERIPHERAL 915
25 FALL 907
26 SYNCOPE 843
27 PERIPHERAL SWELLING 824
28 WEIGHT DECREASED 817
29 ARTHRALGIA 796
30 DYSPNOEA EXERTIONAL 777
31 RIGHT VENTRICULAR FAILURE 762
32 INFUSION SITE PAIN 753
33 CARDIAC FAILURE 736
34 PAIN IN JAW 723
35 DECREASED APPETITE 722
36 FLUSHING 707
37 HOSPITALISATION 699
38 RESPIRATORY FAILURE 674
39 BACK PAIN 632
40 ANAEMIA 628
41 HYPOXIA 621
42 MYALGIA 617
43 WEIGHT INCREASED 617
44 OEDEMA 613
45 NASAL CONGESTION 612
46 DISEASE PROGRESSION 605
47 PALPITATIONS 603
48 FEELING ABNORMAL 581
49 ANXIETY 572
50 RASH 566
51 NASOPHARYNGITIS 563
52 CARDIAC FAILURE CONGESTIVE 555
53 ABDOMINAL PAIN 541
54 ACUTE KIDNEY INJURY 541
55 PULMONARY OEDEMA 531
56 ABDOMINAL PAIN UPPER 528
57 INSOMNIA 527
58 ABDOMINAL DISCOMFORT 498
59 CHEST DISCOMFORT 492
60 INFUSION SITE ERYTHEMA 462
61 SEPSIS 461
62 ATRIAL FIBRILLATION 456
63 EPISTAXIS 441
64 FLUID OVERLOAD 438
65 LOSS OF CONSCIOUSNESS 438
66 PRODUCT USE ISSUE 438
67 INFLUENZA 436
68 PRURITUS 434
69 RENAL FAILURE 422
70 DRUG INTERACTION 416
71 DEHYDRATION 415
72 CARDIAC ARREST 414
73 HEART RATE INCREASED 406
74 CONSTIPATION 404
75 HAEMOGLOBIN DECREASED 399
76 THERAPY NON-RESPONDER 392
77 ABDOMINAL DISTENSION 385
78 HYPERTENSION 378
79 URINARY TRACT INFECTION 376
80 MUSCLE SPASMS 367
81 TACHYCARDIA 363
82 PRODUCT DOSE OMISSION ISSUE 358
83 DRUG DOSE OMISSION 351
84 ERYTHEMA 351
85 ACUTE RESPIRATORY FAILURE 350
86 SWELLING 350
87 CARDIAC DISORDER 344
88 PLEURAL EFFUSION 343
89 SOMNOLENCE 340
90 COVID-19 332
91 GENERAL PHYSICAL HEALTH DETERIORATION 328
92 GAIT DISTURBANCE 326
93 INFECTION 319
94 TOXICITY TO VARIOUS AGENTS 316
95 GASTROINTESTINAL HAEMORRHAGE 307
96 VISUAL IMPAIRMENT 307
97 DEPRESSION 298
98 PREMATURE BABY 297
99 TREMOR 297
100 DRUG ABUSE 294
101 UNEVALUABLE EVENT 292
102 LUNG DISORDER 291
103 TRANSFUSION 286
104 BLOOD PRESSURE DECREASED 284
105 CHILLS 284
106 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 277
107 DYSPEPSIA 277
108 MYOCARDIAL INFARCTION 276
109 PRODUCT DOSE OMISSION 276
110 FOETAL EXPOSURE DURING PREGNANCY 273
111 VISION BLURRED 273
112 PRODUCTIVE COUGH 272
113 ASCITES 269
114 CONFUSIONAL STATE 269
115 DEVICE RELATED INFECTION 268
116 OROPHARYNGEAL PAIN 265
117 INFUSION SITE SWELLING 263
118 MEMORY IMPAIRMENT 263
119 MIGRAINE 259
120 PERICARDIAL EFFUSION 259
121 HYPERHIDROSIS 258
122 DEVICE DISLOCATION 256
123 MUSCULAR WEAKNESS 251
124 BRONCHITIS 250
125 UPPER RESPIRATORY TRACT INFECTION 250
126 HAEMORRHAGE 248
127 HOT FLUSH 248
128 CEREBROVASCULAR ACCIDENT 244
129 BLOOD PRESSURE INCREASED 236
130 DRUG INTOLERANCE 236
131 CHRONIC KIDNEY DISEASE 231
132 ALANINE AMINOTRANSFERASE INCREASED 230
133 GASTROOESOPHAGEAL REFLUX DISEASE 227
134 PRODUCT USE IN UNAPPROVED INDICATION 226
135 GASTROINTESTINAL DISORDER 224
136 BLOOD CREATININE INCREASED 223
137 ERECTILE DYSFUNCTION 223
138 CELLULITIS 221
139 DEVICE ISSUE 220
140 DERMATITIS CONTACT 219
141 JOINT SWELLING 218
142 LUNG TRANSPLANT 218
143 HAEMOPTYSIS 217
144 PREMATURE DELIVERY 216
145 ASPARTATE AMINOTRANSFERASE INCREASED 213
146 PARAESTHESIA 211
147 SEIZURE 210
148 HYPOAESTHESIA 208
149 MATERNAL EXPOSURE DURING PREGNANCY 205
150 RENAL IMPAIRMENT 205
151 EXPOSURE DURING PREGNANCY 204
152 HYPERSENSITIVITY 204
153 ILLNESS 201
154 RHINORRHOEA 200
155 RESPIRATORY DISTRESS 199
156 THROMBOCYTOPENIA 199
157 CYANOSIS 197
158 THERAPY CESSATION 197
159 SINUSITIS 195
160 CATHETERISATION CARDIAC 194
161 INFUSION SITE HAEMORRHAGE 194
162 PLATELET COUNT DECREASED 193
163 TREATMENT NONCOMPLIANCE 193
164 INCORRECT DOSE ADMINISTERED 192
165 BRADYCARDIA 189
166 CARDIO-RESPIRATORY ARREST 185
167 OVERDOSE 185
168 CATHETER SITE ERYTHEMA 183
169 PULMONARY EMBOLISM 182
170 SWELLING FACE 181
171 OXYGEN CONSUMPTION INCREASED 179
172 COMA 176
173 DEVICE LEAKAGE 174
174 THERAPY INTERRUPTED 174
175 PULMONARY ARTERIAL PRESSURE INCREASED 173
176 BLOOD GLUCOSE INCREASED 172
177 VIRAL INFECTION 171
178 INFUSION SITE INFECTION 170
179 THROMBOSIS 169
180 PRESYNCOPE 167
181 INTENTIONAL PRODUCT USE ISSUE 166
182 HYPOKALAEMIA 164
183 LETHARGY 163
184 CONTUSION 162
185 BLOOD POTASSIUM DECREASED 161
186 DRY MOUTH 160
187 WHEEZING 160
188 AGITATION 158
189 DEVICE MALFUNCTION 157
190 INTENTIONAL PRODUCT MISUSE 157
191 FLATULENCE 154
192 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 153
193 BLOOD BILIRUBIN INCREASED 150
194 STRESS 148
195 TINNITUS 148
196 DEVICE OCCLUSION 147
197 INTERSTITIAL LUNG DISEASE 147
198 SEASONAL ALLERGY 146
199 LIVER FUNCTION TEST ABNORMAL 144
200 DRUG HYPERSENSITIVITY 143
201 SEPTIC SHOCK 142
202 CATHETER SITE PAIN 139
203 ARRHYTHMIA 138
204 RESPIRATORY DISORDER 138
205 DEVICE FAILURE 137
206 NECK PAIN 135
207 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 134
208 PRODUCT SUBSTITUTION ISSUE 134
209 RENAL DISORDER 134
210 URTICARIA 134
211 DEVICE INFUSION ISSUE 133
212 CONCOMITANT DISEASE AGGRAVATED 132
213 INFUSION SITE DISCHARGE 132
214 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 132
215 FEELING HOT 131
216 CARDIAC OPERATION 130
217 CARDIOGENIC SHOCK 129
218 DIALYSIS 129
219 HERPES ZOSTER 129
220 HYPERVOLAEMIA 129
221 THROAT IRRITATION 128
222 DYSPHAGIA 127
223 ARTHRITIS 126
224 ALOPECIA 125
225 HEAD INJURY 125
226 MUSCULOSKELETAL PAIN 125
227 TRANSIENT ISCHAEMIC ATTACK 125
228 BLINDNESS 123
229 ADVERSE EVENT 122
230 HYPOGLYCAEMIA 122
231 INFLUENZA LIKE ILLNESS 121
232 SLEEP DISORDER 121
233 AMNESIA 120
234 DRY SKIN 119
235 HALLUCINATION 119
236 MENTAL STATUS CHANGES 119
237 GOUT 118
238 HAEMATOCHEZIA 118
239 BLOOD ALKALINE PHOSPHATASE INCREASED 117
240 MULTIPLE ORGAN DYSFUNCTION SYNDROME 117
241 RECTAL HAEMORRHAGE 117
242 RESPIRATORY TRACT INFECTION 117
243 ASTHMA 116
244 DYSPHONIA 116
245 INFUSION SITE PRURITUS 116
246 NEUROPATHY PERIPHERAL 116
247 SCLERODERMA 115
248 SUBSTANCE USE DISORDER 115
249 LOCALISED INFECTION 114
250 CATHETER SITE INFECTION 113
251 CIRCULATORY COLLAPSE 113
252 LIP SWELLING 113
253 EXERCISE TOLERANCE DECREASED 112
254 HAEMATOCRIT DECREASED 111
255 CATHETER MANAGEMENT 110
256 STAPHYLOCOCCAL INFECTION 110
257 ANGIOEDEMA 109
258 VASCULAR DEVICE INFECTION 109
259 VERTIGO 109
260 INFUSION SITE REACTION 108
261 LIVER DISORDER 108
262 INJECTION SITE PAIN 107
263 HEPATIC ENZYME INCREASED 106
264 PULMONARY CONGESTION 105
265 SKIN ULCER 105
266 SUBARACHNOID HAEMORRHAGE 105
267 BURNING SENSATION 104
268 ATRIAL FLUTTER 103
269 BALANCE DISORDER 103
270 DIZZINESS POSTURAL 103
271 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 103
272 SURGERY 103
273 CARDIOMEGALY 102
274 CATHETER SITE HAEMORRHAGE 102
275 SYSTEMIC LUPUS ERYTHEMATOSUS 102
276 INFUSION SITE INDURATION 101
277 CEREBRAL HAEMORRHAGE 100
278 DIABETES MELLITUS 100
279 DISCOMFORT 100
280 HYPONATRAEMIA 100
281 SUICIDAL IDEATION 100
282 CATHETER SITE DISCHARGE 99
283 COGNITIVE DISORDER 99
284 DISTURBANCE IN ATTENTION 99
285 HEART RATE DECREASED 99
286 LIVER FUNCTION TEST INCREASED 98
287 CLOSTRIDIUM DIFFICILE INFECTION 97
288 HAEMATEMESIS 97
289 INTERNATIONAL NORMALISED RATIO INCREASED 97
290 RHABDOMYOLYSIS 96
291 CARDIAC FAILURE ACUTE 95
292 INTENTIONAL DOSE OMISSION 95
293 COMPLETED SUICIDE 94
294 PURULENT DISCHARGE 94
295 VENTRICULAR TACHYCARDIA 94
296 LOWER RESPIRATORY TRACT INFECTION 93
297 PALLOR 93
298 PNEUMOTHORAX 93
299 UNRESPONSIVE TO STIMULI 93
300 ADVERSE DRUG REACTION 92
301 COMPLICATION ASSOCIATED WITH DEVICE 92
302 DEVICE USE ERROR 92
303 HEPATIC CIRRHOSIS 92
304 POLLAKIURIA 92
305 ACUTE MYOCARDIAL INFARCTION 91
306 DEPRESSED MOOD 91
307 SINUS DISORDER 91
308 BRAIN NATRIURETIC PEPTIDE INCREASED 90
309 DEVICE MAINTENANCE ISSUE 90
310 EMOTIONAL DISTRESS 90
311 THERAPY CHANGE 90
312 RASH PRURITIC 89
313 EYE PAIN 88
314 CATHETER SITE PRURITUS 87
315 DIPLOPIA 87
316 NO ADVERSE EVENT 87
317 HYPERKALAEMIA 86
318 HYPOACUSIS 86
319 INFUSION SITE IRRITATION 86
320 INTENTIONAL OVERDOSE 86
321 INTESTINAL OBSTRUCTION 86
322 OCULAR HYPERAEMIA 86
323 BONE PAIN 85
324 EAR INFECTION 85
325 PANCYTOPENIA 85
326 DEAFNESS 84
327 HIP FRACTURE 84
328 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 84
329 CENTRAL VENOUS CATHETERISATION 83
330 DYSURIA 83
331 RIGHT VENTRICULAR DYSFUNCTION 83
332 SKIN DISCOLOURATION 83
333 CATARACT 82
334 RESPIRATORY SYNCYTIAL VIRUS INFECTION 82
335 TREATMENT FAILURE 82
336 BLOOD PRESSURE ABNORMAL 81
337 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 81
338 PULMONARY FIBROSIS 81
339 C-REACTIVE PROTEIN INCREASED 80
340 PRODUCT ADMINISTRATION INTERRUPTED 80
341 BLISTER 79
342 GASTROENTERITIS VIRAL 79
343 NERVOUSNESS 79
344 SLEEP APNOEA SYNDROME 79
345 TRICUSPID VALVE INCOMPETENCE 79
346 WHITE BLOOD CELL COUNT INCREASED 79
347 ACCIDENTAL OVERDOSE 78
348 LIMB DISCOMFORT 78
349 LIMB INJURY 78
350 WHITE BLOOD CELL COUNT DECREASED 78
351 PSORIASIS 77
352 ANGINA PECTORIS 76
353 MELAENA 76
354 MUSCULOSKELETAL STIFFNESS 76
355 PHOTOPHOBIA 76
356 END STAGE RENAL DISEASE 75
357 PULMONARY HAEMORRHAGE 74
358 PULMONARY VENO-OCCLUSIVE DISEASE 74
359 DEVICE ALARM ISSUE 73
360 HEART RATE IRREGULAR 73
361 NEPHROLITHIASIS 73
362 RESPIRATORY TRACT CONGESTION 73
363 BACTERAEMIA 72
364 CHOLELITHIASIS 72
365 INFUSION SITE WARMTH 72
366 SUDDEN DEATH 72
367 ATRIAL TACHYCARDIA 71
368 JAUNDICE 71
369 MOBILITY DECREASED 71
370 PNEUMONIA ASPIRATION 71
371 PULMONARY HYPERTENSIVE CRISIS 71
372 BLOOD UREA INCREASED 70
373 CARDIAC PACEMAKER INSERTION 70
374 CATHETER PLACEMENT 70
375 DEEP VEIN THROMBOSIS 70
376 FEELING COLD 70
377 GENERALISED OEDEMA 70
378 HYPERSOMNIA 70
379 RHINOVIRUS INFECTION 70
380 RIB FRACTURE 70
381 FACIAL PAIN 69
382 INJECTION SITE ERYTHEMA 69
383 IRRITABILITY 69
384 ISCHAEMIC STROKE 69
385 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 69
386 UPPER GASTROINTESTINAL HAEMORRHAGE 69
387 DEVICE BREAKAGE 68
388 HEAD DISCOMFORT 68
389 PANCREATITIS 68
390 ROAD TRAFFIC ACCIDENT 68
391 TRANSPLANT EVALUATION 68
392 AGGRESSION 67
393 ANOSMIA 67
394 EYE PRURITUS 67
395 FAECES DISCOLOURED 67
396 HAEMODYNAMIC INSTABILITY 67
397 NEOPLASM MALIGNANT 67
398 PRIAPISM 67
399 SINUS CONGESTION 67
400 SPEECH DISORDER 67
401 DYSGEUSIA 66
402 DYSPNOEA AT REST 66
403 EYE SWELLING 66
404 RESPIRATORY ARREST 66
405 RETCHING 66
406 ANHEDONIA 65
407 DIVERTICULITIS 65
408 INFLAMMATION 65
409 LOW BIRTH WEIGHT BABY 65
410 MENTAL DISORDER 65
411 RASH MACULAR 65
412 RED BLOOD CELL COUNT DECREASED 65
413 BLOOD SODIUM DECREASED 64
414 CATHETER SITE SWELLING 64
415 OSTEOPOROSIS 64
416 BLOOD GLUCOSE DECREASED 63
417 DEVICE WIRELESS COMMUNICATION ISSUE 63
418 DISORIENTATION 63
419 INTERNAL HAEMORRHAGE 63
420 POST PROCEDURAL COMPLICATION 63
421 PRODUCT QUALITY ISSUE 63
422 BRAIN FOG 62
423 PAIN OF SKIN 62
424 RESPIRATION ABNORMAL 62
425 VASCULITIS 62
426 GASTRIC DISORDER 61
427 HEPATIC FAILURE 61
428 ILL-DEFINED DISORDER 61
429 IRON DEFICIENCY ANAEMIA 61
430 OSTEOARTHRITIS 61
431 SNEEZING 61
432 THERAPY PARTIAL RESPONDER 61
433 AGEUSIA 60
434 GASTRITIS 60
435 MUSCULOSKELETAL CHEST PAIN 60
436 TACHYPNOEA 60
437 BLOOD IRON DECREASED 59
438 CHOKING 59
439 LUNG INFECTION 59
440 OPTIC ISCHAEMIC NEUROPATHY 59
441 RHEUMATOID ARTHRITIS 59
442 GAMMA-GLUTAMYLTRANSFERASE INCREASED 58
443 HAEMATOMA 58
444 RAYNAUD^S PHENOMENON 58
445 DRUG-INDUCED LIVER INJURY 57
446 LOCALISED OEDEMA 57
447 METABOLIC ACIDOSIS 57
448 RENAL FAILURE ACUTE 57
449 THERAPEUTIC PRODUCT EFFECT DECREASED 57
450 ACUTE RESPIRATORY DISTRESS SYNDROME 56
451 BACTERIAL INFECTION 56
452 BLOOD PRESSURE FLUCTUATION 56
453 CORONARY ARTERY DISEASE 56
454 DEVICE DIFFICULT TO USE 56
455 HEART TRANSPLANT 56
456 LYMPHADENOPATHY 56
457 MUSCLE TWITCHING 56
458 PANIC ATTACK 56
459 ARTHROPATHY 55
460 CYSTITIS 55
461 GENERALISED TONIC-CLONIC SEIZURE 55
462 HAEMOGLOBIN INCREASED 55
463 HOSPICE CARE 55
464 INFUSION SITE RASH 55
465 LACRIMATION INCREASED 55
466 PERICARDITIS 55
467 PULSELESS ELECTRICAL ACTIVITY 55
468 RASH ERYTHEMATOUS 55
469 ANAPHYLACTIC REACTION 54
470 DISEASE COMPLICATION 54
471 EYE IRRITATION 54
472 NIGHT SWEATS 54
473 SECRETION DISCHARGE 54
474 SKIN EXFOLIATION 54
475 SPINAL FRACTURE 54
476 SUBDURAL HAEMATOMA 54
477 BLOOD CREATINE PHOSPHOKINASE INCREASED 53
478 CHROMATURIA 53
479 COLITIS 53
480 GAIT INABILITY 53
481 HAEMATURIA 53
482 HEPATOMEGALY 53
483 POLYURIA 53
484 PULMONARY THROMBOSIS 53
485 RESTLESS LEGS SYNDROME 53
486 RESTLESSNESS 53
487 SKIN INFECTION 53
488 BLOOD POTASSIUM INCREASED 52
489 CARDIAC FAILURE CHRONIC 52
490 DECREASED ACTIVITY 52
491 DYSSTASIA 52
492 INFUSION SITE NODULE 52
493 LIVER TRANSPLANT 52
494 PROSTATE CANCER 52
495 RIGHT VENTRICULAR DILATATION 52
496 SUPRAVENTRICULAR TACHYCARDIA 52
497 TENSION HEADACHE 52
498 DEVICE POWER SOURCE ISSUE 51
499 DRUG DEPENDENCE 51
500 LABORATORY TEST ABNORMAL 51
501 LUNG NEOPLASM MALIGNANT 51
502 ORTHOSTATIC HYPOTENSION 51
503 POOR QUALITY SLEEP 51
504 SWOLLEN TONGUE 51
505 HAEMORRHOIDS 50
506 MECHANICAL VENTILATION 50
507 ORTHOPNOEA 50
508 THERAPEUTIC RESPONSE UNEXPECTED 50
509 TROPONIN INCREASED 50
510 DEVICE RELATED SEPSIS 49
511 GASTROENTERITIS 49
512 IMPAIRED GASTRIC EMPTYING 49
513 INFUSION SITE DISCOMFORT 49
514 STENT PLACEMENT 49
515 SUICIDE ATTEMPT 49
516 TRANSAMINASES INCREASED 49
517 APHASIA 48
518 BLOOD CULTURE POSITIVE 48
519 COAGULOPATHY 48
520 DYSARTHRIA 48
521 HEPATIC FUNCTION ABNORMAL 48
522 HYPERGLYCAEMIA 48
523 INFUSION SITE DISCOLOURATION 48
524 NEURALGIA 48
525 OXYGEN SATURATION ABNORMAL 48
526 PULMONARY ALVEOLAR HAEMORRHAGE 48
527 UPPER LIMB FRACTURE 48
528 ASPHYXIA 47
529 HEMIPARESIS 47
530 LIVER INJURY 47
531 MIOSIS 47
532 OXYGEN THERAPY 47
533 SKIN IRRITATION 47
534 CAROTID ARTERY OCCLUSION 46
535 CHRONIC RESPIRATORY FAILURE 46
536 DELIRIUM 46
537 ELECTROLYTE IMBALANCE 46
538 GYNAECOMASTIA 46
539 TUBULOINTERSTITIAL NEPHRITIS 46
540 ATELECTASIS 45
541 BLOOD COUNT ABNORMAL 45
542 DRY EYE 45
543 FEBRILE NEUTROPENIA 45
544 HYPERTHYROIDISM 45
545 PACKED RED BLOOD CELL TRANSFUSION 45
546 SKIN DISORDER 45
547 SLEEP TERROR 45
548 UNINTENTIONAL MEDICAL DEVICE REMOVAL 45
549 BODY TEMPERATURE INCREASED 44
550 DEMENTIA 44
551 DEPRESSED LEVEL OF CONSCIOUSNESS 44
552 ENDOTRACHEAL INTUBATION 44
553 JOINT INJURY 44
554 MUSCULOSKELETAL DISCOMFORT 44
555 PRURITUS GENITAL 44
556 RENAL INJURY 44
557 WOUND 44
558 CAESAREAN SECTION 43
559 CARDIOSPASM 43
560 HEPATIC ENCEPHALOPATHY 43
561 HIGH RISK SEXUAL BEHAVIOUR 43
562 HYPOPHAGIA 43
563 INFUSION SITE INFLAMMATION 43
564 KIDNEY INFECTION 43
565 PALMOPLANTAR KERATODERMA 43
566 SINUS TACHYCARDIA 43
567 SKIN LACERATION 43
568 SMALL INTESTINAL OBSTRUCTION 43
569 CRYING 42
570 EAR DISCOMFORT 42
571 ENCEPHALOPATHY 42
572 HEPATOTOXICITY 42
573 PARACENTESIS 42
574 PRODUCT LEAKAGE 42
575 THERAPEUTIC RESPONSE DECREASED 42
576 THROMBOSIS IN DEVICE 42
577 TRACHEOSTOMY 42
578 URINARY INCONTINENCE 42
579 ALTERED STATE OF CONSCIOUSNESS 41
580 ANKLE FRACTURE 41
581 CONTRAINDICATED PRODUCT ADMINISTERED 41
582 INJURY 41
583 LEFT VENTRICULAR FAILURE 41
584 MEDICATION ERROR 41
585 PETECHIAE 41
586 STOMATITIS 41
587 URINE OUTPUT DECREASED 41
588 BEDRIDDEN 40
589 BRONCHOSPASM 40
590 CARDIAC TAMPONADE 40
591 CHOKING SENSATION 40
592 HEPATIC STEATOSIS 40
593 HIP ARTHROPLASTY 40
594 MULTI-ORGAN FAILURE 40
595 SHOCK 40
596 STAPHYLOCOCCUS TEST POSITIVE 40
597 THIRST 40
598 THROAT TIGHTNESS 40
599 ASPIRATION 39
600 BLOOD URINE PRESENT 39
601 CARDIAC ABLATION 39
602 EAR PAIN 39
603 EXTRA DOSE ADMINISTERED 39
604 FOETAL GROWTH RESTRICTION 39
605 MULTIPLE ALLERGIES 39
606 MYDRIASIS 39
607 NO THERAPEUTIC RESPONSE 39
608 RALES 39
609 SPUTUM DISCOLOURED 39
610 VIRAL UPPER RESPIRATORY TRACT INFECTION 39
611 ACCIDENTAL EXPOSURE TO PRODUCT 38
612 CARDIOPULMONARY FAILURE 38
613 COVID-19 PNEUMONIA 38
614 FEELING JITTERY 38
615 HAEMORRHAGE INTRACRANIAL 38
616 HERNIA 38
617 MOOD ALTERED 38
618 PANCREATITIS ACUTE 38
619 PERIPHERAL COLDNESS 38
620 SYSTEMIC SCLERODERMA 38
621 AMMONIA INCREASED 37
622 BLOOD PRESSURE SYSTOLIC INCREASED 37
623 CATHETER SITE RASH 37
624 DEVICE CONNECTION ISSUE 37
625 ELECTROCARDIOGRAM QT PROLONGED 37
626 FLANK PAIN 37
627 FUNGAL INFECTION 37
628 GALLBLADDER DISORDER 37
629 IMPAIRED HEALING 37
630 INFUSION RELATED REACTION 37
631 INFUSION SITE EXTRAVASATION 37
632 LIGAMENT SPRAIN 37
633 MANIA 37
634 NASAL DRYNESS 37
635 ABNORMAL BEHAVIOUR 36
636 CONCOMITANT DISEASE PROGRESSION 36
637 FEEDING DISORDER 36
638 FOOT FRACTURE 36
639 INJECTION SITE DISCHARGE 36
640 INJECTION SITE HAEMORRHAGE 36
641 LOWER LIMB FRACTURE 36
642 MACULOPATHY 36
643 PREGNANCY 36
644 PRODUCT DOSE OMISSION IN ERROR 36
645 PRODUCT SUPPLY ISSUE 36
646 PULMONARY MASS 36
647 RIGHT VENTRICULAR HYPERTROPHY 36
648 TASTE DISORDER 36
649 TOOTH INFECTION 36
650 ULCER 36
651 WALKING DISTANCE TEST ABNORMAL 36
652 ABDOMINAL PAIN LOWER 35
653 BLOOD PRESSURE SYSTOLIC DECREASED 35
654 CARDIAC FLUTTER 35
655 CHOLECYSTECTOMY 35
656 CONVULSION 35
657 COR PULMONALE 35
658 DRUG LEVEL INCREASED 35
659 NEPHROGENIC ANAEMIA 35
660 OBSTRUCTIVE AIRWAYS DISORDER 35
661 TRANSPLANT 35
662 TYPE 2 DIABETES MELLITUS 35
663 URINARY RETENTION 35
664 BLOOD CHOLESTEROL INCREASED 34
665 CEREBRAL INFARCTION 34
666 CLOSTRIDIUM DIFFICILE COLITIS 34
667 COLD SWEAT 34
668 FEMUR FRACTURE 34
669 FREQUENT BOWEL MOVEMENTS 34
670 INJECTION SITE PRURITUS 34
671 LUNG INFILTRATION 34
672 NEPHROPATHY 34
673 OBESITY 34
674 ORAL CANDIDIASIS 34
675 OSTEOMYELITIS 34
676 PARANOIA 34
677 PSORIATIC ARTHROPATHY 34
678 RESPIRATORY RATE INCREASED 34
679 RETINAL VEIN OCCLUSION 34
680 SCAR 34
681 SEROTONIN SYNDROME 34
682 SUDDEN CARDIAC DEATH 34
683 UNDERDOSE 34
684 VAGINAL HAEMORRHAGE 34
685 VENTRICULAR FIBRILLATION 34
686 WEIGHT FLUCTUATION 34
687 COLITIS ULCERATIVE 33
688 DEVICE USE ISSUE 33
689 EMBOLISM 33
690 EPILEPSY 33
691 HAEMODIALYSIS 33
692 HYPERBILIRUBINAEMIA 33
693 POST PROCEDURAL HAEMORRHAGE 33
694 PULMONARY PAIN 33
695 SUSPECTED COUNTERFEIT PRODUCT 33
696 ACUTE PULMONARY OEDEMA 32
697 BLOOD MAGNESIUM DECREASED 32
698 CHOLECYSTITIS 32
699 DISEASE RECURRENCE 32
700 EMPHYSEMA 32
701 HYPERCAPNIA 32
702 IDIOPATHIC PULMONARY FIBROSIS 32
703 IMPAIRED QUALITY OF LIFE 32
704 INFUSION SITE BRUISING 32
705 INJECTION SITE SWELLING 32
706 MENORRHAGIA 32
707 OSTEOPENIA 32
708 PRODUCT ADMINISTRATION ERROR 32
709 RASH PAPULAR 32
710 RETINAL ARTERY OCCLUSION 32
711 SCIATICA 32
712 BREAST CANCER 31
713 DIABETES MELLITUS INADEQUATE CONTROL 31
714 INFUSION SITE MASS 31
715 KNEE ARTHROPLASTY 31
716 MUSCLE STRAIN 31
717 NEUTROPHIL COUNT INCREASED 31
718 NIGHTMARE 31
719 PROCEDURAL COMPLICATION 31
720 PRODUCT PRESCRIBING ISSUE 31
721 SKIN BURNING SENSATION 31
722 TERMINAL STATE 31
723 VENTILATION PERFUSION MISMATCH 31
724 ACIDOSIS 30
725 BLADDER CANCER 30
726 BLOOD PRESSURE DIASTOLIC INCREASED 30
727 BRAIN OEDEMA 30
728 CARBON DIOXIDE INCREASED 30
729 CARDIOMYOPATHY 30
730 CROHN^S DISEASE 30
731 DRUG WITHDRAWAL SYNDROME 30
732 ERUCTATION 30
733 FACE OEDEMA 30
734 GLYCOSYLATED HAEMOGLOBIN INCREASED 30
735 LACTIC ACIDOSIS 30
736 LOCAL SWELLING 30
737 MOOD SWINGS 30
738 MOUTH ULCERATION 30
739 MYOCARDIAL ISCHAEMIA 30
740 MYOPATHY 30
741 NEUTROPENIA 30
742 PNEUMONIA BACTERIAL 30
743 TOOTH EXTRACTION 30
744 TOOTHACHE 30
745 VISUAL FIELD DEFECT 30
746 ABNORMAL LOSS OF WEIGHT 29
747 DRUG USE DISORDER 29
748 DYSCHROMATOPSIA 29
749 DYSKINESIA 29
750 ECZEMA 29
751 FAILURE TO THRIVE 29
752 GLAUCOMA 29
753 HYPOTONIA 29
754 IMMUNISATION 29
755 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 29
756 INFUSION SITE OEDEMA 29
757 LEUKOCYTOSIS 29
758 LOWER GASTROINTESTINAL HAEMORRHAGE 29
759 OCULAR DISCOMFORT 29
760 PELVIC FRACTURE 29
761 PLASMA CELL MYELOMA 29
762 POISONING 29
763 PSYCHOTIC DISORDER 29
764 RESPIRATORY TRACT INFECTION VIRAL 29
765 STAPHYLOCOCCAL SEPSIS 29
766 ABSCESS 28
767 ANAL INCONTINENCE 28
768 ANGER 28
769 ANURIA 28
770 BLINDNESS UNILATERAL 28
771 CARDIOVERSION 28
772 COUNTERFEIT PRODUCT ADMINISTERED 28
773 DEVICE PHYSICAL PROPERTY ISSUE 28
774 DRUG ADMINISTRATION ERROR 28
775 EATING DISORDER 28
776 EYE DISORDER 28
777 GASTRIC ULCER 28
778 HEART RATE ABNORMAL 28
779 HYPOCALCAEMIA 28
780 INFUSION SITE CELLULITIS 28
781 MITRAL VALVE INCOMPETENCE 28
782 OSTEONECROSIS 28
783 PARANASAL SINUS DISCOMFORT 28
784 PARKINSON^S DISEASE 28
785 PNEUMONITIS 28
786 SARS-COV-2 TEST POSITIVE 28
787 STAPHYLOCOCCAL BACTERAEMIA 28
788 SUBSTANCE ABUSE 28
789 VASODILATATION 28
790 ASPIRATION PLEURAL CAVITY 27
791 BLOOD PRESSURE DIASTOLIC ABNORMAL 27
792 CATHETER SITE INFLAMMATION 27
793 DEVICE KINK 27
794 EYE INFLAMMATION 27
795 GLOMERULAR FILTRATION RATE DECREASED 27
796 HERNIA REPAIR 27
797 INFUSION SITE VESICLES 27
798 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 27
799 MOUTH HAEMORRHAGE 27
800 MUSCLE TIGHTNESS 27
801 NASAL DISCOMFORT 27
802 OVARIAN CYST 27
803 SHOCK HAEMORRHAGIC 27
804 VISUAL ACUITY REDUCED 27
805 ACUTE HEPATIC FAILURE 26
806 ARTHROPOD BITE 26
807 BASAL CELL CARCINOMA 26
808 BONE DENSITY DECREASED 26
809 CHOLESTASIS 26
810 ECONOMIC PROBLEM 26
811 EYE HAEMORRHAGE 26
812 GASTRIC HAEMORRHAGE 26
813 HEPATIC CONGESTION 26
814 MALNUTRITION 26
815 PARANASAL SINUS HYPERSECRETION 26
816 PRODUCT PRESCRIBING ERROR 26
817 QUALITY OF LIFE DECREASED 26
818 APHONIA 25
819 ATRIAL SEPTAL DEFECT REPAIR 25
820 BLOOD URIC ACID INCREASED 25
821 BRAIN INJURY 25
822 COLON CANCER 25
823 ELECTROCARDIOGRAM ABNORMAL 25
824 ERECTION INCREASED 25
825 GINGIVAL BLEEDING 25
826 GROIN PAIN 25
827 HYPOMAGNESAEMIA 25
828 HYPOTHYROIDISM 25
829 INTERNATIONAL NORMALISED RATIO DECREASED 25
830 IRON DEFICIENCY 25
831 JOINT STIFFNESS 25
832 LEFT VENTRICULAR HYPERTROPHY 25
833 MULTIPLE SCLEROSIS RELAPSE 25
834 NEONATAL RESPIRATORY DISTRESS SYNDROME 25
835 ORAL PAIN 25
836 PHARYNGITIS 25
837 PHOTOSENSITIVITY REACTION 25
838 SELF-MEDICATION 25
839 SKIN LESION 25
840 SKIN REACTION 25
841 SUBSTANCE USE 25
842 TACHYARRHYTHMIA 25
843 TOOTH ABSCESS 25
844 ACNE 24
845 APNOEA 24
846 BACK DISORDER 24
847 BONE DISORDER 24
848 CARDIAC VALVE DISEASE 24
849 CARPAL TUNNEL SYNDROME 24
850 CHORIORETINOPATHY 24
851 CONGESTIVE CARDIOMYOPATHY 24
852 FAECES SOFT 24
853 FULL BLOOD COUNT DECREASED 24
854 HEART VALVE INCOMPETENCE 24
855 HEPATITIS 24
856 HIATUS HERNIA 24
857 HYSTERECTOMY 24
858 IMMUNODEFICIENCY 24
859 INCORRECT DRUG ADMINISTRATION RATE 24
860 INFUSION SITE ABSCESS 24
861 LIPASE INCREASED 24
862 LOSS OF LIBIDO 24
863 NERVOUS SYSTEM DISORDER 24
864 PLATELET COUNT INCREASED 24
865 POLYCYTHAEMIA 24
866 PRODUCT CONTAMINATION 24
867 PSEUDOMONAS INFECTION 24
868 TOOTH DISORDER 24
869 BACK INJURY 23
870 BLOOD LACTIC ACID INCREASED 23
871 BLOOD PRESSURE SYSTOLIC ABNORMAL 23
872 BLOOD TEST ABNORMAL 23
873 BRONCHOPULMONARY DYSPLASIA 23
874 CARDIOVASCULAR DISORDER 23
875 CHEMOTHERAPY 23
876 COMPARTMENT SYNDROME 23
877 CONJUNCTIVAL HYPERAEMIA 23
878 DIABETIC KETOACIDOSIS 23
879 DIZZINESS EXERTIONAL 23
880 DRY THROAT 23
881 ECHOCARDIOGRAM ABNORMAL 23
882 EJECTION FRACTION DECREASED 23
883 EXPIRED PRODUCT ADMINISTERED 23
884 FACIAL PARALYSIS 23
885 FEAR 23
886 FRACTURE 23
887 HAEMATOCRIT INCREASED 23
888 HALLUCINATION, VISUAL 23
889 HYPOVOLAEMIA 23
890 INJECTION SITE INFECTION 23
891 INSURANCE ISSUE 23
892 KNEE OPERATION 23
893 LARGE INTESTINE POLYP 23
894 LEUKOPENIA 23
895 MEDICAL DEVICE COMPLICATION 23
896 ONYCHOMYCOSIS 23
897 PHARYNGEAL SWELLING 23
898 PHARYNGITIS STREPTOCOCCAL 23
899 RESPIRATORY ACIDOSIS 23
900 SARCOIDOSIS 23
901 SCRATCH 23
902 SINUS HEADACHE 23
903 SLUGGISHNESS 23
904 THYROID DISORDER 23
905 WITHDRAWAL SYNDROME 23
906 ANGIOPLASTY 22
907 APPENDICITIS 22
908 APPLICATION SITE PRURITUS 22
909 BOWEL MOVEMENT IRREGULARITY 22
910 CONCUSSION 22
911 CORONARY ARTERIAL STENT INSERTION 22
912 DERMATITIS ALLERGIC 22
913 DEVICE ADHESION ISSUE 22
914 DIASTOLIC DYSFUNCTION 22
915 DRUG ERUPTION 22
916 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 22
917 EYE INFECTION 22
918 HYPERPARATHYROIDISM SECONDARY 22
919 INCORRECT DOSE ADMINISTERED BY DEVICE 22
920 IRRITABLE BOWEL SYNDROME 22
921 MENTAL IMPAIRMENT 22
922 OESOPHAGITIS 22
923 PREMATURE LABOUR 22
924 PRODUCT AVAILABILITY ISSUE 22
925 RENAL TUBULAR NECROSIS 22
926 RIGHT VENTRICULAR SYSTOLIC PRESSURE INCREASED 22
927 ROTATOR CUFF SYNDROME 22
928 SUBSTANCE ABUSER 22
929 TELANGIECTASIA 22
930 TEMPERATURE INTOLERANCE 22
931 TOOTH LOSS 22
932 APATHY 21
933 APPLICATION SITE ERYTHEMA 21
934 BIOPSY LIVER 21
935 CARDIAC MURMUR 21
936 CATHETER SITE IRRITATION 21
937 CATHETER SITE RELATED REACTION 21
938 DEPENDENCE ON OXYGEN THERAPY 21
939 DRUG EFFECT LESS THAN EXPECTED 21
940 EMOTIONAL DISORDER 21
941 EXPOSURE VIA SKIN CONTACT 21
942 GASTROINTESTINAL TUBE INSERTION 21
943 HAEMOLYTIC ANAEMIA 21
944 HEART AND LUNG TRANSPLANT 21
945 HYPOKINESIA 21
946 INCREASED APPETITE 21
947 ISCHAEMIA 21
948 LEFT VENTRICULAR DYSFUNCTION 21
949 MALIGNANT NEOPLASM PROGRESSION 21
950 MICTURITION URGENCY 21
951 MULTIPLE SCLEROSIS 21
952 PARAESTHESIA ORAL 21
953 RASH GENERALISED 21
954 VARICOSE VEIN 21
955 ANAPHYLACTIC SHOCK 20
956 BREATH SOUNDS ABNORMAL 20
957 CATHETERISATION CARDIAC ABNORMAL 20
958 DERMATITIS 20
959 DERMATITIS ATOPIC 20
960 EJACULATION FAILURE 20
961 FIBROMYALGIA 20
962 FINGER AMPUTATION 20
963 FOOD POISONING 20
964 FRUSTRATION TOLERANCE DECREASED 20
965 GASTROINTESTINAL INFECTION 20
966 HYPERNATRAEMIA 20
967 HYPOTHERMIA 20
968 IMPAIRED WORK ABILITY 20
969 INCREASED TENDENCY TO BRUISE 20
970 INJECTION SITE REACTION 20
971 INTERVERTEBRAL DISC PROTRUSION 20
972 INTRA-ABDOMINAL FLUID COLLECTION 20
973 JOINT DISLOCATION 20
974 LACERATION 20
975 LEG AMPUTATION 20
976 LIMB OPERATION 20
977 LIVE BIRTH 20
978 MALIGNANT MELANOMA 20
979 NEEDLE ISSUE 20
980 NERVE INJURY 20
981 NOCTURIA 20
982 NORMAL NEWBORN 20
983 OLIGURIA 20
984 PORTAL HYPERTENSION 20
985 POSTOPERATIVE WOUND INFECTION 20
986 PROCEDURAL PAIN 20
987 PROTEINURIA 20
988 PRURITUS GENERALISED 20
989 PULMONARY ARTERIAL PRESSURE ABNORMAL 20
990 PULMONARY ARTERY DILATATION 20
991 RIGHT VENTRICULAR ENLARGEMENT 20
992 SENSORY DISTURBANCE 20
993 SPINAL COMPRESSION FRACTURE 20
994 SPLENOMEGALY 20
995 AORTIC STENOSIS 19
996 ATRIAL SEPTAL DEFECT 19
997 ATRIOVENTRICULAR BLOCK COMPLETE 19
998 BLOOD ALBUMIN DECREASED 19
999 CARDIAC DISCOMFORT 19